Sitemap

Sitemap

Posts

Pages

#HowMuchIsEnough Awareness Campaign
Thank You
Fundraising
- In Memoriam
- Legacy Gifts
- Tell us your story
- Guide to Fundraising
- Take on a challenge event
- Sponsored Head Shave
- Coffee morning or afternoon tea
- Woburn Abbey Triathlon
- Skydive
- Mount Everest
- Weddings
- Corporate Fundraising & Charitable Giving
Shop
Cart
Checkout
My account
Sitemap
Training plans
Triathlon Kit
Sun Safety & Skin Awareness
Donate
Home
- About Us
  - Privacy Notice and Disclaimer
- Contact Us
- Objectives
- Specialist Committees
Information & Support
- Video: Immunotherapy Treatment for Patients
- What is Melanoma?
- Summaries of Scientific Papers
  - Superiority of combined BRAF and MEK inhibition versus BRAF inhibition alone: Lay Summary
  - Overcoming Resistance to Dabrafenib: Lay Summary
- Taking Part in Clinical Trials: Video
- Library
  - Melanoma Focus Booklet
  - Melanoma World Society Newsletters
- AVAST-M Trial – Final Results Announced
- Melanoma Taskforce Report
  - Melanoma Care Pathway
- Weblinks
- Other Organisations
- Clinical Trials
- Patient Decision Aid
- Sentinel Node Biopsy Guideline
News & Updates
- News & Updates
- Access for Patients to New Drug Combinations
Support
- Helpline – 0808 801 0777
- Cambridge Melanoma Support Group
- Understanding sunbeds
Trustees, Management & Advisers
Activities
- Summary: What We Do
- Mucosal Melanoma Guidelines Project
  - Mucosal Melanoma Guidelines – Resources
- Research: Patient Impact Programme
- Uveal Melanoma Guidelines Project
- Melanoma Database Project
Meetings
- Events Calendar
- Subscription Rates and Registering for Meetings as a Non-Member
- Registering for Meetings as a Member
- Regional Meeting, Leeds, 17 May 2019
- Focus on Melanoma Meeting, 18 October 2019
Members’ Area
- Professional Membership of Melanoma Focus
- Newcastle University’s Melanoma Ulceration Study: Technical Overview
- Follow-Up of High Risk Cutaneous Melanoma: Position Paper
- Overcoming Resistance to Dabrafenib: Technical Summary

Events

News

NHS confirms revised stopping and retreatment rules for immunotherapy patients

NHS England has confirmed its financial support for the re-starting of anti PD-1 treatments for patients with melanoma. Clinicians will now be able to halt treatment after two years confident that funding for the drugs will be available if the disease progresses and the treatment needs to be resumed in the future.

Melanoma Focus launches Sentinel Node Biopsy Guideline

New guidance on this surgical procedure and related issues, including the need for completion lymphadenectomy, has been released by a 70-strong group of clinicians, nurses & patient representatives who met in May 2018 to discuss and reach consensus on this controversial topic. Advances in melanoma treatments and the findings of recent trials prompted this review.

First safe and effective adjuvant therapy for melanoma is now available on the NHS

Patients and clinicians have welcomed the announcement of a new adjuvant therapy drug combination. ‘This is the first treatment to be made available that shows a significant reduction in the risk of dying from the recurrence of melanoma after surgery,’ says Melanoma Focus Chairman Professor Paul Lorigan. ‘This milestone will transform outcomes for many patients’.

Fundraising Events

ASICS Manchester Marathon 2019

7 April 2018 – Run with Melanoma Focus to help raise money for research into the causes and treatment of melanoma.

100 Miles in May Challenge Event

100 Miles in May is a challenge event that anyone can take part in whether they are a cyclist, runner, walker or swimmer. Join the challenge and help raise money in the fight against melanoma.

Professional Events

Tweets